Biosafety and Biosecurity Manual V1.5

Biosafety and Biosecurity Manual
Table of Contents
1. Introduction ........................................................................................................................................ 5
1.1 Purpose and Scope........................................................................................................................ 5
1.2 Policy ............................................................................................................................................. 5
1.3 Objectives...................................................................................................................................... 6
2. Management Structure and Responsibility ........................................................................................ 7
2.1 Deputy Vice Chancellor (Research) ............................................................................................... 7
2.2 Institutional Biosafety Committee ................................................................................................ 7
2.3 University Biosafety Officer .......................................................................................................... 7
2.4 Deans and Heads of Department .................................................................................................. 7
2.5 Laboratory and Facility Managers................................................................................................. 7
2.6 Chief Investigators ........................................................................................................................ 7
2.7 Staff, Students and Volunteers ..................................................................................................... 8
3. Health Management ........................................................................................................................... 8
3.1 Immunisation ................................................................................................................................ 8
3.1.1 Tetanus................................................................................................................................... 8
3.1.2 Hepatitis ................................................................................................................................. 9
3.1.3 Q fever.................................................................................................................................... 9
3.2 Precautions for Pregnant Women ................................................................................................ 9
3.3 Personal Hygiene .......................................................................................................................... 9
4. Research Approval and Risk Management ....................................................................................... 10
4.1 The Institutional Biosafety Committee (IBC) .............................................................................. 10
4.2 Biosafety Management and Support .......................................................................................... 10
4.3 Risk management........................................................................................................................ 11
4.3.1 Hierarchy of control ............................................................................................................. 11
4.3.2 Responsibility of the Chief Investigator ............................................................................... 12
4.3.3 Responsibility of Research and Technical Personnel ........................................................... 12
4.3.4 Register of Biological Hazards .............................................................................................. 12
4.3.5 Inductions............................................................................................................................. 13
4.3.6 Training ................................................................................................................................ 13
4.3.7 Laboratory Access and Authorisation .................................................................................. 13
4.3.8 Personal Protective Equipment ........................................................................................... 13
4.3.9 Working After Hours ............................................................................................................ 14
4.3.10 Safe Work Procedures........................................................................................................ 14
Macquarie University Biosafety and Biosecurity Manual Version 1.5

Contact: [email protected] Date: June 2018
5. Standard Precautions ........................................................................................................................ 14
6. Microorganisms and Biohazardous Materials .................................................................................. 15
6.1 Introduction ................................................................................................................................ 15
6.2 Risk groups .................................................................................................................................. 16
6.2.1 Risk group classification for human and animal infectious microorganisms ....................... 16
6.2.2 Risk group classification for plant infectious microorganisms............................................. 16
6.2.3 Risk group classification for invertebrates carrying infectious microorganisms ................. 17
6.3 Physical Containment ................................................................................................................. 17
7. Work with Genetically Modified Organisms (GMOs)........................................................................ 18
7.1 Introduction ................................................................................................................................ 18
7.2 Types of Dealings ........................................................................................................................ 19
7.2.1 Exempt Dealings................................................................................................................... 19
7.2.2 Notifiable Low Risk Dealings ................................................................................................ 19
7.2.3 Dealings Not Involving Intentional Release ......................................................................... 19
7.2.4 Dealings Involving Intentional Release ................................................................................ 20
7.3 Synthetically Modified Organisms .............................................................................................. 20
8. Biosecurity......................................................................................................................................... 20
9. Biosecurity and Quarantine .............................................................................................................. 21
9.1 Introduction ................................................................................................................................ 21
9.2 Imported Biologicals ................................................................................................................... 21
9.3 Biosecurity Approved Arrangements .......................................................................................... 22
10. Security Sensitive Biological Agents (SSBAs) ................................................................................... 22
10.1 Introduction .............................................................................................................................. 22
10.2 SSBA Classification .................................................................................................................... 23
10.3 Research Approval and Reporting ............................................................................................ 23
11. Laboratory Animals ......................................................................................................................... 24
11.1 Introduction .............................................................................................................................. 24
11.2 Use of Animals at Macquarie University ................................................................................... 24
12. Facility Work Practices .................................................................................................................... 25
12.1 General Rules and Regulations ................................................................................................. 25
12.2 PC1 Facility ................................................................................................................................ 25
12.3 PC2 Facility ................................................................................................................................ 26
12.4 PC3 Facilities ............................................................................................................................. 27
12.5 GMO Physical Containment Facilities ....................................................................................... 28

12.6 Biosecurity Approved Arrangements (AA) ................................................................................ 28
13. Biological Spills ................................................................................................................................ 28
13.1 Introduction .............................................................................................................................. 28
13.2 Disinfectants ............................................................................................................................. 28
14. Laundering of Laboratory Gowns.................................................................................................... 29
15. Disposal of Biological Waste ........................................................................................................... 29
15.1 Introduction .............................................................................................................................. 29
15.2 Waste Tracking Requirements .................................................................................................. 29
15.3 Segregation of Laboratory Waste ............................................................................................. 30
15.4 Clinical and Biological Waste .................................................................................................... 30
15.4.1 Microorganisms, clinical or other infectious waste ........................................................... 31
15.4.2 GMO waste ........................................................................................................................ 31
15.4.3 Sharps waste ...................................................................................................................... 32
15.4.4 Cytotoxic waste .................................................................................................................. 32
15.4.5 Animal carcasses ................................................................................................................ 32
15.4.6 Drugs of addiction .............................................................................................................. 33
16. Appendix 1 Biosafety Legislation .................................................................................................... 33
17. Appendix 2 Clean up biological spills – Safe Work Procedure ........................................................ 35
18. Appendix 3 Summary of recommended disinfectants for microbiological laboratories ................ 38
19. Appendix 4: Good Hand washing technique ................................................................................... 40
20. Appendix 5: The hierarchy of risk control ....................................................................................... 41
20.1 Key Terms.................................................................................................................................. 41
20.2 Hierarchy of risk control............................................................................................................ 41
21. Appendix 6: Step by step process for the safe removal of PPE ..................................................... 43
22. Appendix 7: Examples of microorganisms for risk groups 2 and 3 ................................................ 44
22.1 Risk group 2 microorganisms .................................................................................................... 44
22.2 Risk group 3 microorganisms .................................................................................................... 47
23. Appendix 8 Examples of zoonotic diseases..................................................................................... 48

1. Introduction
1.1 Purpose and Scope
There are many biological hazards (biohazards) that can be encountered in University teaching and
research laboratories. Laboratories where biologicals are used and stored must have the
appropriate training, approvals, practices and equipment in place to manage the associated risks.
This manual provides information on relevant legislative requirements and safe work practices when
working with or being exposed to biological materials. The guidelines within this manual have been
developed to complement other biosafety and WHS management information from:
• Australian Standards AS/NZS2243.3 series (SAI Global available through the library)
• The Office of the Gene Technology Regulator (OGTR)
• Australian Department of Agriculture and Water Resources (DAWR)
• Security Sensitive Biological Agents Regulatory Scheme
• The World Health Organisation
• SafeWork NSW
This manual covers basic biological safety requirements and it is expected that individual Faculties
and Departments will develop and implement local safety instructions that are designed to meet
their specific requirements but remain compatible with these guidelines. This manual should be
used in conjunction with the Macquarie University General Laboratory Safety Guidelines and The
Macquarie University Code for the Responsible Conduct of Research.
1.2 Policy
The University Biosafety and Biosecurity Policy is the enabling policy for this guide. Key provisions of
the Policy state that Macquarie University will:
• Maintain an appropriately constituted Institutional Biosafety Committee (IBC) who is
provided with the resources required for institutional monitoring.
• Ensure, through the IBC, that all research, teaching and services at the University
involving biohazardous materials, genetically modified organisms (GMOs), security
sensitive biological agents (SSBAs) and agents requiring quarantine containment are
conducted in accordance with the relevant legislation, regulations, guidelines and
codes.
• Ensure dealings with GMOs, the use of microorganisms classified as risk group 2 and
above, animals potentially containing zoonotic microorganisms classified as risk
group 2 and above, SSBAs or agents requiring containment or approval under the
Quarantine Act 1908, are not commenced without the prior approval of the IBC.
• Ensure it maintains certification of OGTR and quarantine approved facilities.
• Enable the IBC to conduct monitoring inspections, at least annually, of the
University’s laboratories to ensure compliance with the relevant Acts, Regulations,
guidelines and codes.
• Conduct an institutional biosafety workshop at least annually for personnel involved
in the acquisition, handling, storage, removal or disposal of biological materials on
University premises to ensure that such personnel are aware of potential risks.

Macquarie University expects its staff, HDR candidates, students, researchers, contractors and
visitors to adhere to this manual and to the University's Biosafety and Biosecurity Policy to maintain
a safe and healthy environment by minimising the risks from biological work procedures. To reach
this standard, work with biological material will be guided by current Acts, Regulations, Codes of
Practice, Australian Standards and University policy and procedures. See Appendix 1 for a detailed
list of biosafety legislation.
Macquarie University requires that:
• Biological materials are obtained, transported, stored and disposed of in an ethical

and responsible manner.
• Biological materials are handled in a way that will not put at risk the health and
safety of any individual.
• University staff and students comply with training requirements.
• University staff and students are provided with sufficient information, instruction,
and supervision to handle microorganisms, biohazardous materials and GMOs
safely.
1.3 Objectives
The objectives of this manual are to ensure that:
• All staff, students, researchers, and visitors are aware of the biological hazards,
legislative requirements, Australian Standards and University policy and procedures
associated with working with microorganisms and biohazardous material.
• Staff, students and researchers are aware of their responsibilities in regard to
biological safety at Macquarie University.
• All staff, students, researchers, and visitors receive appropriate training and
information that enables them to recognise potential hazards associated with their
work.
• All research and teaching involving GMOs, SSBAs, risk group 2 and above
microorganisms, clinical and diagnostic samples, animal and human tissues, blood or
body fluids, and materials requiring quarantine containment is assessed by the IBC.
The use of humans, animals and their tissue, blood or body fluids in research and
teaching receives approval from the appropriate (Human or Animal) Ethics
Committees prior to commencement of work.
• All research and teaching involving non-pathogenic microorganisms or other
biological material or agent unlikely to cause human or animal disease or harm the
environment are risk assessed by the Chief Investigator or Unit Convenor prior to
the commencement of work.
• Biohazardous operations involving microorganisms or diagnostic samples are
performed in the appropriate manner and physical containment facility according to
their risk groups.
• Risk management procedures are in place in the event of biological spills.
• Appropriate waste disposal systems are in place for biological materials.

2. Management Structure and Responsibility
2.1 Deputy Vice Chancellor (Research)
The Deputy Vice Chancellor (Research) is responsible to the Vice Chancellor for the Macquarie
University IBC and that committee’s implementation of requirements as specified by the OGTR and
other regulatory bodies.
2.2 Institutional Biosafety Committee

Under OGTR legislation, all work involving GMO’s must be reviewed by IBC. The Macquarie
University IBC is responsible for:
• Reviewing research and teaching applications which involve the use of and dealings
with risk group 2 and above microorganisms, animals potentially containing risk
group 2 and above zoonotic microorganisms, GMOs, quarantine materials and
SSBAs.
• Ensuring that the use of GMOs within the university is conducted in compliance with
the Gene Technology Act 2000 and the Gene Technology Regulations 2001.
2.3 University Biosafety Officer

The University Biosafety Officer is authorised to advise and report on biosafety and quarantine
matters. The Biosafety Officer assists the IBC in ensuring compliance of OGTR and Quarantine
approved facilities.
2.4 Deans and Heads of Department

Deans and Heads of Department are responsible for ensuring that all employees and students
receive appropriate information and training necessary for them to work and conduct their research
safely and in accordance with this manual. They are to ensure that Technical and Facility Managers
have resources to develop and implement procedures necessary to ensure that biosafety guidelines
are met.
2.5 Laboratory and Facility Managers

Laboratory and Facility Managers are responsible for monitoring laboratory access and
authorisation. They are to ensure that staff and students teaching, working or conducting research in
their laboratories have undergone the appropriate laboratory safety induction prior to commencing.
Managers of certified facilities (OGTR and quarantine) are to maintain all laboratory documentation
required for their certification.
2.6 Chief Investigators

Chief Investigators (including Principal Investigators, Academic Supervisors, Research Supervisors
and Unit Conveners) are responsible for the health and safety of the undergraduate and
postgraduate students they supervise in addition to volunteers and staff employed under them.
They are to ensure that their students and staff have received the appropriate laboratory safety
induction and training to enable them to undertake their work safely and that associated risk
assessments have been completed.

2.7 Staff, Students and Volunteers
Staff, students and volunteers working with biological hazards must ensure that they follow safety
guidelines set out by Macquarie University and their respective Facility Manager and Chief
Investigators. They are to ensure that their actions do not put themselves, or any other individual at
risk.
3. Health Management
3.1 Immunisation
People working with infectious organisms, blood or bodily fluids or in animal holding facilities
should routinely review their need for immunisation against preventable disease. Additionally,
people who are immunosuppressed, immunocompromised or involved in any of the following
activities should consider their need for immunisation:
• Field work
• Working with waste or contaminated water or soil
• Working with animals or insects
• First aid administration
It is mandatory for Chief Investigators to undertake a thorough risk management assessment to

identify risks specific to any human pathogen brought into a facility and to which they or other
research members may be exposed.
For a comprehensive guide to immunisations please visit:

• The Australian Immunisation Handbook 10th edition
• World Health Organisation website
• The Australian Federal Government Smart Traveller
• NSW Health occupational immunisation requirements
Tetanus, Hepatitis A, Hepatitis B and Q Fever are notifiable diseases in all states and territories in
Australia. In NSW if an employee contracts Q fever it must be reported to WorkCover.
3.1.1 Tetanus
Tetanus is a disease caused by a toxin produced by Clostridium tetani. Any tetanus-prone wound can
become contaminated with C. tetani. Tetanus-prone wounds are those other than clean, minor cuts
and include:
• Wounds where disinfection has been delayed by more than 4 hours

• Compound fractures
• Bites
• Deep penetrating wounds
• Wounds containing contamination or foreign bodies (wood, dust, soil, manure)
Those at risk of tetanus include:
• Anyone at risk of scratches, bites and cuts from animals or their cages
• Anyone handling C. tetani or its toxin

• Outdoor workers
3.1.2 Hepatitis
Hepatitis A is one of several different hepatitis viruses that can cause infections and damage to the
liver. Hepatitis A is caused by the hepatitis A virus and it is highly contagious and can be particularly
dangerous for people with pre-existing liver problems. The virus is spread by the faecal oral route
and can survive on hands, in food and in water for prolonged periods of time.
Hepatitis B is a potentially life-threatening disease caused by the hepatitis B virus. The Hepatitis B
virus is spread through contact with blood and other bodily secretions. Immunisation is an effective
way of protecting against hepatitis A and B viruses. Currently for Hepatitis C there is no
immunisation or completely effective treatment.
Those at risk of hepatitis infections include anyone who:
• Handles a hepatitis virus
• Is exposed to human faecal material, blood, liver tissue and bile and other bodily
secretions
• Works with non-human primates
• First aiders
3.1.3 Q fever
Q fever is amongst the most serious infective hazards and is a WorkCover-reportable illness in NSW.
Q fever is a zoonotic infectious disease caused by the bacterium Coxiella burnetii, which can be
harboured in numerous domesticated and wild animals. C. burnetii is highly infectious and is
transmitted to humans via aerosols from contaminated body fluids of infected animals.
People considered at risk of exposure are those working with or handling:
• Coxiella burnetii as part of their work
• Animals potentially infected, especially pregnant animals, including native animals
(e.g. kangaroos), companion animals (cats and dogs) and stock animals (pigs, sheep,
cattle)
• Unfixed tissues, including carcasses from potentially infected animals
• Unfixed human samples (blood or tissue) that could be from individuals with Q fever
3.2 Precautions for Pregnant Women

Minimising laboratory risks for pregnant women is especially important due to the sensitivity of the
foetus to specific biological agents. All lab workers should know the hazards associated with the
materials with which they work and it is important to recognise that an individual’s susceptibility to
those hazards may change due to factors such as pregnancy. In all cases, a pregnant woman should
discuss her laboratory environment with her medical care professional and provide specific
information about potential exposures.
3.3 Personal Hygiene

To prevent the spread of laboratory contaminants, it is important to use good microbiological
techniques, wear the provided personal protective equipment (PPE) and ensure that hands are
washed after completing a procedure, and before leaving the laboratory. See Appendix 3 for the
recommended antiseptics for hand washing and Appendix 4 for good hand washing technique.

4. Research Approval and Risk Management
4.1 The Institutional Biosafety Committee (IBC)
The Macquarie University IBC help to minimise the risks associated with working with biological
materials by asking Chief Investigators to complete an online Biosafety Application with an inbuilt
risk assessment. Biosafety Applications are maintained by the IBC and are subject to routine
monitoring to ensure the specified risk management strategies are being followed. The IBC also
confirms that particular laboratories meet a physical containment level under OGTR, quarantine and
AS/NZS 2243.3 specifications. The IBC is charged with monitoring all GMO, recombinant and
synthetic biology projects and reports annually to the OGTR.
At Macquarie University, Biosafety Applications are required for all research, teaching or services
that involve the use of biological materials. Biosafety Applications are submitted online and are
reviewed by the IBC via an expedited review process between February 1st – November 30th.
Please be advised that the IBC will be out of session from December 1st to January 31st.
A Biosafety Application form for work involving the use of risk group 1 microorganisms (including
animals with the potential to carry risk group 1 zoonoses) or other biological material or agent that is
unlikely to cause human or animal disease or harm the environment is still required, however it is
treated as a notification.
Biosafety Applications are approved for a period of five years, and for GMO projects approval is
under the provision of annual reporting. All Biosafety Applications are subject to IBC audit and
inspection.
4.2 Biosafety Management and Support

Work involving any of the below categories must not commence until IBC approval has been granted
and the Macquarie University introductory biosafety course has been completed :
• Microorganisms classified as risk group 2 and above

• GMOs
• SSBAs
• Agents requiring containment under the Biosecurity Act 2015
• Animals with the potential to carry zoonotic agents classified as risk group 2 and
above
• Human and animal clinical and diagnostic samples
A Biosafety Application form for work involving the use of risk group 1 microorganisms (including
animals with the potential to carry risk group 1 zoonoses) or other biological material or agent that is
unlikely to cause human or animal disease or harm the environment is still required, however it is
treated as a notification.
Applications must be submitted via the Biosafety Management System using your OneID and
password. All applications must be approved by the Chief Investigator prior to an IBC submission.
10

Biosafety Applications are approved for a period of five years, and for GMO projects approval is
under the provision of annual reporting. All biosafety applications are subject to IBC audit and
inspection.
The use of humans, animals and their tissue, blood or body fluids in research and teaching may
require additional approval from the appropriate Human or Animal Ethics Committees prior to
commencement of work.
For more information and supporting resources relating to submitting applications, safety
documentation, the review process, and managing approved projects please refer to the Biosafety
Management support page located on the University Wiki.
For clarification of GMO Dealings visit the OGTR website or the Macquarie University GMO
Classification tables.
The Macquarie University introductory biosafety course is available online using iLearn. Please click
on the following link and self-enrol using your OneID:
Macquarie University introductory biosafety course
4.3 Risk management
4.3.1 Hierarchy of control

A risk assessment section has been built into the Biosafety Application. The information requested
on the risk assessment section is necessary to give the IBC and Chief Investigator enough
information to decide if the work can be carried out safely and, in a laboratory, equipped to meet
biosafety needs.
The risk assessment section follows a globally accepted risk management process known as the
hierarchy of control. The hierarchy of control creates a systematic approach to manage biological
risks safely by providing a structure to select the most effective control measures to eliminate or
reduce the risk of hazards associated with a particular research project. The hierarchy of control has
six levels of control, the most effective measure is at the top, the least effective at the bottom. As
best practice it is recommended to try to incorporate the use of high end controls such as
elimination, substitution, isolation and engineering controls as opposed to the use of low end
controls such as administrative and the use of personal protective equipment. The hierarchy of
control is included in all Risk Assessment Forms to provide a systematic approach for managing the
risk associated with biological research hazards.
The hierarchy of control involves the following six steps;
1. Elimination – remove the cause of danger completely (e.g. inactivate infectious source).
2. Substitution – controls the hazard by replacing it with a less risky way to achieve the same
outcome (e.g. use of a less pathogenic organism).
3. Engineering /bioengineering controls – Isolate the hazard from people and the environment by
using physical or biological safety features to plant or equipment (e.g. Physical containment facility,
Class II biosafety cabinet vaccines).
11

4. Administration – use of administrative controls to lessen the risk (e.g. signage, risk assessments
and safe work procedures, training).
5. Personal Protective Equipment (PPE) – provides a personal barrier between the user and the
infectious/toxic substance (e.g. gloves, eye protection, lab coat).
Note: The use of PPE to reduce the risk of an hazard should always be the last resort.
For more detailed information please refer to Appendix 5: The hierarchy of risk control.
4.3.2 Responsibility of the Chief Investigator

The Chief Investigator must ensure:
• Research and technical personnel have read risk assessments before work starts.
• Hard copies of risk assessments are available in the laboratory for reference.
• Research and technical personnel have received sufficient training and/or
supervision to allow them to work and handle biological agents and materials in a
safe manner.
• Faulty equipment is reported and removed from service where a danger exists.
• Safe Working Procedures are followed.
• Safety rules are followed.
• Emergency equipment is serviced.
• The physical containment level is appropriate for the risk group.
• Incidents, accidents and near miss occurrences are reported to the health and safety
unit.
• Regular compliance checks and safety tours are carried out and any findings are
documented.
• That they familiarise themselves with the AS/NZ 2243.3 standard.
4.3.3 Responsibility of Research and Technical Personnel

Research and technical personnel include, but is not limited to staff, students, animal care staff,
research assistants and volunteers. Research personnel must ensure that they:
• Read the relevant risk assessment and relevant guidance material.

• Follow all relevant Safe Work Procedures and guidelines.
• Report any faulty equipment.
• Attend required training.
• Speak to a supervisor or laboratory manager about any safety concerns.
• Comply with the relevant safety rules and guidelines.
4.3.4 Register of Biological Hazards

The register of biological hazards lists all biologically hazardous materials and microorganisms used
and stored in teaching and research laboratories. Hard copies of risk assessments are to be
maintained in these laboratories and made available to personnel who conduct work in those
laboratories. The register must be updated annually and should also indicate whether any SSBAs are
being held.
12

4.3.5 Inductions
Any person entering a facility must comply with the local processes for induction. The level and
detail of the safety induction should depend upon the risk and legislative requirements associated
with procedures/work carried out and the materials and equipment stored within the lab. Induction
records must be kept and maintained. Access and authorization requirements will be determined on
the risk associated with the procedures/work carried out and the materials stored within the
laboratory.
4.3.6 Training
In order to reduce the inherent risks associated with biohazards, training, hazard awareness,
knowledge of the biological agent, good habits, caution, attentiveness and concern for the health of
co-workers are prerequisites for all individuals.
The University Research Office runs a Biosafety Workshop which outlines the legislative framework
for research using biological agents, potential risks associated with biological research, the
application process for such research and provides guidance on how to complete a risk assessment.
This workshop is mandatory for individuals intending to work with GMOs, biohazardous materials or
working in any of the Universities Physical Containment facilities. It is expected that individuals
refresh the Biosafety Workshop every three years. The IBC maintains all biosafety training records.
For further information please contact your supervisor, laboratory manager or the University
Biosafety Officer. In addition, the University has a Health and Safety unit for advice and guidance
[email protected].
Quarantine training is mandatory for individuals working with quarantine materials or those working
within any of the University’s Quarantine Approved Premises (QAP). For further details contact the
QAP Facility Manager or the Biosafety Officer. The University IBC requires a copy of the certificates
once training has been successfully completed.
4.3.7 Laboratory Access and Authorisation

It is a condition of entry that all persons understand the general laboratory safety rules and accept
their responsibility under WHS Legislation to adhere to the safety rules at all times. Individual
Departments should implement local laboratory safety instructions that are designed to meet their
specific requirements. It is a requirement that inductions are performed for all University
laboratories. Induction records are to be maintained by the laboratory Manager. Access to general
laboratories is under the authorisation of the Laboratory Manager or Laboratory Supervisor. Access
and authorisation to physical containment facilities is under the direction from the Facility Manager
and may be dependent on completion of the Biosafety Workshop. Refer to the respective Facility
Manager for further information on access to their laboratories.
4.3.8 Personal Protective Equipment

Personal protective equipment (PPE) is specialised clothing or equipment worn by laboratory
personnel for protection against exposure to aerosols, splashes and accidental inoculation. PPE must
be worn while working in the laboratory and must not be taken home or worn outside the
laboratory. PPE equipment is selected to suit the type of work being performed and the potential
risk of exposure. Consult AS/NZS 2243.1:2005 for detailed information regarding the different types
of PPE. All PPE is to be removed and hands decontaminated prior to leaving the laboratory or
containment facility. Appendix 6 details a step by step process for safely removing PPE.
13

At a minimum, enclosed footwear is mandatory for all University research and teaching laboratories.
Within research laboratories a properly fastened laboratory coat that protects the arms and body
must be worn at all times unless lesser requirements can be justified by a risk assessment.
Laboratories will supply safety glasses, goggles, face shields and gloves which meet Australian
standards and appropriate to the type of work being performed.
4.3.9 Working After Hours

The University defines its business hours as Monday – Friday 7:00 am to 10:00 pm and weekends
8:00 am – 6:00 pm. After hours work is defined as the period outside of these business hours and
Public Holidays. All individuals occupying a building after hours are required to advise the Security
Information Centre (ext: 7112) of their presence in the building and an estimate of their length of
stay.
4.3.10 Safety Documentation

Safe Work Instructions (SWIs) and Standard Operating Procedures (SOPs) outline the safe way to
undertake a task and may be developed for techniques, processes and equipment to minimise any
risk to individuals when working with biohazardous materials. Safety documentation is being
developed and implemented across the University. Visit the university wiki websites below for
current approved documents and templates:
Biosafety Management support page
Macquarie University Health and Safety
It is advised that individual research and teaching facilities have a procedure manual which highlights
any specific requirements, standard processes and hazards associated with the work space. All staff
and students are advised to familiarise themselves with it and consult the relevant Manager with
any questions.
5. Standard Precautions
Human error, poor laboratory techniques and misuse of equipment cause the majority of laboratory
injuries and laboratory acquired infections. The World Health Organization (WHO) has compiled a
chapter of technical methods that are designed to avoid or minimise the most commonly reported
problems of this nature. For further detailed information see the WHO Laboratory Biosafety Manual,
Chapter 12
The National Health and Medical Research Council (NHMRC) have recommended adoption of the
term ‘Standard Precautions’ as the basic risk minimisation strategy for handling potentially infectious
material. Standard precautions are recommended for the care and treatment of all patients in the
clinical environment and in the handling of:
• Microbiological agents
• Blood (including dry blood)
• Body fluids, secretions, excretions (excluding sweat)
• Non-intact skin
• Mucous membranes
14

Standard precautions are work practices required for the basic level of infection control and they
include the use of:
• Good microbiological practices (aseptic techniques)

• Good hygiene practices (particularly washing and drying hands before and after
patient and sample contact and when leaving the laboratory)
• Use of PPE (including the wearing of gloves, lab coats, gowns, plastic aprons, masks,
eye protection)
• Waterproof coverings over any skin breaks
• Appropriate procedures for the handling and disposal of contaminated wastes
• Appropriate procedures for the handling and disposal of sharps
When used in combination with physical containment work practices described in

AS/NZS2243.3:2010, this meets the requirements of implementing standard precautions. Specific
AS/NZS 2243.3:2010 sections relating to physical containment work practices are listed below:
• Section 5.2.3 and 5.3.6 of a PC1 and PC2 Laboratory Containment Facility
• Section 6.4.3 and 6.5.5 of a PC1 and PC2 Animal Containment Facility
• Section 7.2.4 and 7.3.5 of a PC1 and PC2 Plant Containment Facility
• Section 8.2.4 and 8.3.5 of a PC1 and PC2 Invertebrate Containment Facility
Further infection control guidelines can also be found on the Department of Health website.
6. Microorganisms and Biohazardous Materials

6.1 Introduction
The laboratory contains many potential biological hazards. These include working with
microorganisms (bacteria, fungi, viruses and parasites), genetically modified organisms, humans,
animals, and their associated tissues and biohazardous substances such as prions, human blood,
blood products, body fluids and raw and treated sewerage. The basic approach to working with
microorganisms is to regard them as potential pathogens and to handle them with standard
microbiological techniques. Such techniques help minimize the risk to laboratory staff, the
environment and to maintain purity of strains of isolates. All work with microorganisms and
biohazardous materials must be carried out according to the requirements detailed in the AS/NZS
2243.3:2010 Safety in Laboratories, Part 3: Microbiological safety and containment. Compliance with
the relevant sections of AS/NZS 2243.3 is considered a minimum requirement for anyone handling
microorganisms
Microorganisms vary widely in their infectivity. This is partly due to differences in the portal of entry
(skin, ingestion or via the respiratory tract), the physiology of the microorganism, the infectious dose
and the ability of the microorganism to overcome intrinsic immune and other host defences.
Laboratory acquired infections may arise through:
• Inhalation through the production of aerosols from processes such as centrifugation,

pipetting, opening cultures or flaming contaminated loops.
• Ingestion from accidental splashing into the mouth or contaminated hands.
15

• Sharps injuries via needle pricks, cuts with contaminated glass, and bites and
scratches from animals.
• Transfer through open wounds or across mucosal membranes (eyes, mouth and
nose).
6.2 Risk groups

The Australian Standard AS/NZS 2243.3:2010 classifies infectious microorganisms into risk groups.
AS/NZS 2243.3:2010 lists risk groups by microorganism type (eg: viruses, bacteria, parasites, fungi)
and further divides the lists into human/animal, plant and invertebrate infectious microorganisms.
Safe work practices and physical containment levels for each group are detailed within the AS/NZS
2243.3:2010 standard. A list of risk group 2, 3 and 4 organisms can be found in Appendix 7.
6.2.1 Risk group classification for human and animal infectious microorganisms
Risk group classification for humans and animals is based on the agent’s pathogenicity, mode of
transmission, host range, the availability of preventative measures and the availability of effective
treatment.
Risk group 1 (low individual and community risk) – a microorganism that is unlikely to cause human
or animal disease.
Risk group 2 (moderate individual risk, limited community risk) – a microorganism that is unlikely to
be a significant risk to laboratory workers, the community, livestock, or the environment; laboratory
exposures may cause infection, but effective treatment and preventative measures are available,
and the risk of spread is limited.
Risk group 3 (high individual risk, limited to moderate community risk) – a microorganism that
usually causes serious human or animal disease and may present a significant risk to laboratory
workers. It could present a limited to moderate risk if spread in the community or the environment,
but there are usually effective preventative measures or treatment available.
Risk group 4 (high individual and community risk) – a microorganism that usually produces life
threatening human or animal disease, represents a significant risk to laboratory workers and may be
readily transmissible from one individual to another. Effective treatment and preventative measures
are not usually available.
6.2.2 Risk group classification for plant infectious microorganisms

The risk grouping of plant infectious microorganisms is primarily concerned with containment of
plant pathogens to avoid risk to the environment. Factors considered in relation to the risk from
plant infectious microorganisms are the ecological or economic impact; the agents presence in
Australia or New Zealand; ease of spread; and the agents host range.
Plant risk group 1 – a microorganism that is unlikely to be a risk to plants, industry, a community or
region and is already present and widely distributed.
Plant risk group 2 – a microorganism that is a low to moderate risk to plants, industry, a community
or region and is present but not widely distributed.
16

Pant risk group 3 – a microorganism that is a significant risk to plants, industry, a community or
region and is exotic but with limited ability to spread without the assistance of a vector.
Plant risk group 4 – a microorganism that is a highly significant risk to plants, industry, a community
or region and is exotic and readily spread naturally without the assistance of a vector.
6.2.3 Risk group classification for invertebrates carrying infectious microorganisms

The risks posed by invertebrates are based on the microorganism that they may be harbouring.
Factors considered in relation to their risk are based on; risk to laboratory workers, host range,
economical/ecological impact, geographical distribution and ability to disperse. Some examples
include viruses in mosquitos, Borrelia in soft ticks and trypanosomes in Triatmid bugs.
Invertebrate risk group 1 – microorganisms that are carried by invertebrates where the
microorganisms are unlikely to be a risk to humans or to the environment and are already present
and widely distributed.
microorganisms are a low to moderate risk to humans or to the environment and are present but
not widely distributed. They have a limited ability to disperse because of low persistence of the
microorganism outside the host. They are carried by invertebrates that are un likely to be able to
disperse or can be readily controlled.
microorganisms are a significant risk to humans or to the environment and are exotic and have the
ability to disperse with or without the aid of a vector. They are carried by invertebrates that are able
to disperse.
microorganisms are a highly significant risk to humans or to the environment and are exotic and
readily able to disperse with or without the aid of a vector. The microorganisms may be carried by
invertebrates that are difficult to detect visually.
6.3 Physical Containment

Containment of microorganisms involves a combination of buildings, engineering, equipment,
worker practices and training to handle microorganisms safely. Physical containment is the term
used to describe procedures and structures designed to reduce or prevent the release of viable
organisms into the outside environment. The physical containment level used relates to the risk
group classification of the microorganism, i.e. Physical Containment Level 2 for risk group 2. In some
circumstances the physical containment level required for a particular microorganism may depend
on the work being performed (e.g. Human Immunodeficiency Virus which is classified as both a risk
group 2 and 3 microorganism). There are four classifications of Physical Containment Facilities and
are identified by the ‘PC’ prefix followed by numbers 1 – 4. Not all laboratories operating within the
University are certified containment facilities. Certain types of GMO and quarantine related dealings
are required to be conducted in a certified facility.
PC1 Facilities – A PC 1 laboratory or facility is suitable for work with microorganisms where the
hazard levels are low, and where standard laboratory practice can adequately protect laboratory or
17

facility personnel. This level of laboratory is usually suitable for undergraduate teaching laboratories.
Specimens that have been inactivated or fixed may be handled in PC 1 facilities.
PC2 Facilities – A PC2 Laboratory or Facility is required for all work with microorganisms or material
likely to contain microorganisms that are classified as risk group 2. If working with specimens
containing microorganisms transmissible by the respiratory route or if the work produces a
significant risk to humans or the environment from the production of infectious aerosols, a biological
safety cabinet must be used.
PC3 Facilities – A PC3 laboratory or facility is required for all work with microorganisms or material
likely to contain microorganisms that are classified as risk group 3. A PC3 laboratory or facility
provides additional building features and services to minimize the risk of infection to individuals, the
community, and the environment.
PC4 Facilities – This is the highest Physical Containment level and due to the highly hazardous nature
of this work, rigorous requirements must be adhered to in these facilities. This level of laboratory or
facility is required for work with microorganisms classified as risk group 4 microorganisms and other
dangerous agents.
7. Work with Genetically Modified Organisms (GMOs)

7.1 Introduction
Work involving genetic manipulation or the use of genetically modified organisms (GMOs) is
regulated by the Gene Technology Act 2000 and the Gene Technology Regulations 2001 through the
national Office of the Gene Technology Regulator (OGTR). The legislative mandate of the OGTR is to
“prevent harm to human health and safety and the environment by regulating use of GMOs in
Australia’.
A GMO is defined as:
• An organism that has been modified by gene technology, or

• An organism that has inherited particular traits from an organism (the initial
organism), being traits that occurred in the initial organism because of gene
technology, or
• Anything declared by the regulations to be a genetically modified organism, or that
belongs to a class of entities declared by the regulations to be genetically modified
organisms
Dealings with, in relation to a GMO, means the following:
• Conduct experiments with the GMO

• Make, develop, produce or manufacture the GMO
• Breed the GMO
• Propagate the GMO
• Use the GMO in the course of manufacture of an entity that is not the GMO
• Grow, raise or culture the GMO
• Import, transport or dispose of a GMO
18

The Macquarie University IBC is accredited by the OGTR to provide on-site monitoring of all teaching
and research proposals of work involving the use of GMOs, and to act on behalf of the OGTR and the
University to ensure that the Act, Regulations and guidelines are followed. All work with GMOs
must:
• Have written approval from the IBC before commencement

• If the GMO is a vertebrate animal or cephalopod, then an animal ethics application is
also required
• Comply with the Gene technology Act 2000, Gene technology Regulations 2001 and
OGTR guidelines
7.2 Types of Dealings

There are a number of different classes of GMO dealings. The type of authorisation required for each
class is based on the level of risk that the dealings may pose to people and the environment. These
classes of dealings and the respective authorisation processes are described below.
7.2.1 Exempt Dealings

Exempt Dealings are described in Schedule 2 of the Regulations and are a GMO category assessed as
posing very low risk. The only legislative requirement for exempt dealings is that they must not
involve an intentional release of a GMO into the environment. The OGTR does not require annual
reporting of Exempt Dealings.
Exempt Dealings do not require a specified level of containment. If Exempt Dealings occur in
uncertified facilities, those facilities must comply with the AS/NZS 2243.3:2010, Part 3:
Microbiological Safety and Containment. The regulator has produced Guidance Notes for the
Containment of Exempt Dealings, to provide guidance to persons conducting Exempt Dealings. Prior
to commencement, approval from the IBC is required.
7.2.2 Notifiable Low Risk Dealings

Notifiable Low Risk Dealings (NLRDs) are described in Schedule 3 of the Regulations and are a GMO
category assessed as posing low risk to people and the environment provided the risk is properly
managed. As a requirement of the Regulations, NLRDS must not be intentionally released and must
be reported to the OGTR. NLRDs must be approved by the IBC and it is a condition of approval that
the chief investigators complete an Annual Progress Report. NLRDs must be conducted by
appropriately trained persons and must be transported, stored and disposed of in accordance with
OGTR guidelines. NLRDs must be conducted within an OGTR certified facility. Macquarie University
has certified PC1 and PC2 Facilities.
7.2.3 Dealings Not Involving Intentional Release

Dealings Not Involving Intentional Release (DNIR) are described in Schedule 3 of the regulations and
must be licensed by the regulator. DNIRs are subject to case by case assessments by the OGTR and a
license will only be granted once the OGTR is satisfied that any risks posed by the dealings are able
to be managed so as to protect the health and safety of people and the environment. Some
examples of DNIR dealings are: clinical trials involving GMOs, genetic modifications that may
increase the pathogenicity or toxicity of the GMO, and dealings involving pathogens that require PC3
or PC4 containment. Applications for DNIRs are first submitted and approved by the IBC before being
19

passed on to the OGTR. The OGTR has 90 days to approve a license. DNIRs must be conducted in a
PC2 or higher OGTR certified facility.
7.2.4 Dealings Involving Intentional Release

Dealings Involving Intentional Release (DIRs) are dealings conducted outside containment facilities,
for example GM Crops. DIRs must be licensed by the regulator and applications must include a risk
assessment and risk management plan. All applications are submitted to the IBC before being passed
on to the OGTR. The OGTR has default timeframe of 225 working days to decide on a DIR
application. If the project is a ‘limited and controlled’ release the approval timeframe is 150-170
working days.
7.3 Synthetically Modified Organisms

Synthetic biology is a multidisciplinary and rapidly evolving field. It can be summarised as the design
and construction of new biological parts, devices and systems that do not exist in nature, and the re-
design of existing, natural biological systems for research and industrial purposes. The effect of
synthetically modified organisms (SMOs) on biological diversity or the environment is not
understood.
Currently there is no internationally agreed consensus about a definition of synthetic biology or its
potential regulatory and risk assessment challenges. The United Nation’s Convention on Biological
Diversity (CBD) has formerly urged for regulation and that member countries (which includes
Australia) follow a precautionary approach to synthetic biology. The CBDs decision on synthetic
biology urges all member countries to:
• Follow a precautionary approach to synthetic biology.

• Set up systems to regulate the environmental release of any synthetic biology
organisms or products. These regulations must ensure that activities in one country
cannot harm the environment of another. (Article 3 of the CBD)
• Ensure that no synthetic biology organisms are released for field trials without a
formal prior risk assessment.
• Submit synthetic biology organisms, components and products to scientific
assessments that consider risks to conservation and sustainable use of biodiversity
as well as human health, food security and socio-economic considerations.
• Encourage research funds to assess the safety of synthetic biology as well the socio-
economic impacts of the technology.
• Support developing countries to develop their capacity to assess synthetic biology.
8. Biosecurity
Biosecurity is a critical part of the government’s efforts to prevent, respond to and recover
biologicals that threaten the health of humans and animals, the environment, and the economy.
Specific laboratory biosecurity processes should be developed by facilities dealing with quarantine
materials and SSBAs to ensure security measures are designed to prevent loss, theft, misuse,
diversion or intentional release of pathogens or toxins that have the potential to cause significant
damage to human health, the environment and the Australian economy.
20

Biosecurity in Australia is the responsibility of two Federal Government Departments which oversee
all importation, exportation and use of biological materials of biosecurity concern:
Department of Agriculture and Water Resources – Prevent and control the importation and use of
biological materials and are currently acting under the Biosecurity Act 2015.
Department of Health – (Formerly Department of Health and Aging) Prevent the deliberate release
of harmful biological agents such as viruses, bacteria, fungi and toxins. Currently acting under the
National Health Security Act 2007, National Health Security Regulations 2008 and the SSBA
Regulatory Scheme.
Strict control measures have been put in place for the importation, exportation and use of these
biological materials. Please refer to the specific website for more detailed information.
9. Biosecurity and Quarantine

9.1 Introduction
The Department of Agriculture and Water Resources (DAWR) (formerly Department of Agriculture,
prior to that Department of Agriculture, Fisheries and Forestry: Biosecurity and prior to that AQIS)
administers the importation and use of biological products to ensure the safe handling, security and
disposal of such products in Australia. The aim of the DAWR is to prevent or control entry,
establishment or spread of pests and diseases that will or could cause significant damage to humans,
animals, plants, the environment or the economy. Imported biological materials should be
considered as potentially infectious and handled and disposed of accordingly. The DAWR has specific
regulations and requirements regarding the use (import, use, storage, and disposal) of agents
requiring containment or approval under the Biosecurity Act, 2015.
9.2 Imported Biologicals

Imported biological materials are considered to pose a potential quarantine risk. Imported biological
materials are products containing material from human, animal, plant or microbial origin and include
foods, therapeutics, laboratory materials and vaccines. Any person wishing to import biological
materials may be required to have a Permit to Import Quarantine Material from the DAWR. Since
January 2015, some of the conditions relating to quarantine compliance have changed; visit the
DAWR and BICON websites for further detailed information. The university has a multi-user BICON
account, to join please email [email protected].
It is mandatory to keep records of imported goods and should include the following details:
• Date the material was received

• Quarantine entry number and import permit number
• Name of the supplier
• Description of material
• Batch number
• Proposed research and analysis details
• Details of any special treatments
• Date when research or analysis was completed
21

• Methods and dates of disposal
Items are usually assessed by the DAWR as unrestricted, restricted or prohibited. Persons wanting to
use restricted materials are required to obtain a permit for importation and use of the materials. The
conditions of use will be detailed on the import permit. Some imported biological materials may
need to be kept in Biosecurity Approved Arrangements (AAs; previously termed QAPs).
It is necessary to obtain an in vivo approval from the DAWR for the use of restricted imported
biological products in non-laboratory animals and plants. Please note that an in vivo approval does
not act as an import permit.
9.3 Biosecurity Approved Arrangements

Biosecurity AAs are containment facilities that have been approved by the DAWR to hold biological
materials that are a concern to the Australian environment. The DAWR determines the level of
quarantine containment required (BC1 – BC4) and this is stated on the import permit. There are
several different classes of AAs and each type, and level has certain requirements governing its
operation. Class 5 AAs relate to the Facilities at Macquarie University, within this class there are four
different sets of criteria (5.1 – 5.4) for corresponding quarantine containment levels (BC1 – BC4).
Macquarie University has Class 5 BC1 and BC2 Facilities. Please refer to the AA Facility DAWR
information page for detailed information on the regulations associated with the different AA types
(microbiological, animal and plant facilities).
All AA users must:
• Obtain DAWR import permits and in vivo approvals as required

• Undertake online DAWR training as advised by the Facility Manager
• Complete the Macquarie University Fit and Proper Person Self Declaration and lodge
with the respective Facility Manager
• Comply with DAWR legislation and AS/NZS2243.3:2010 standards
• Ensure that all biological waste is disposed of appropriately
• Comply with conditions as described in the import permit
10. Security Sensitive Biological Agents (SSBAs)

10.1 Introduction
Security-sensitive biological agents (SSBAs) are biological agents that may be deliberately used to
harm human and animal health or the Australian economy. They consist of infectious agents, such as
bacteria and viruses, as well as toxins derived from plants or microorganisms. In 2009 the Federal
Department of Health (DoH) implemented the SSBA Regulatory Scheme which includes:
• The National Health Security Act 2007

• National Health Security Regulation, 2008
• The Security Sensitive Biological Agent Standards
The scheme was implemented to improve the security of biological agents of concern in Australia.
The scheme regulates the acquisition, isolation, storage, handling, transport and disposal of SSBAs.
22

10.2 SSBA Classification
SSBAs are categorised into two lists, Tier 1 and Tier 2. Regulation of Tier 1 list agents came into
effect in January 2009 and that of Tier 2 agents in January 2010.
Individuals are in breach of the SSBA Regulatory Scheme if they have not registered their individual
SSBA’s by 31st January 2010 with the Department of Health. Registration of SSBA’s requires the
development of numerous documents, review of these documents by a committee, as well as
requiring certain levels of security on the individual laboratory where the organisms are stored or
used.
Tier 1 Agents Tier 2 Agents

Abrin (reportable quantity 5mg) African swine fever virus
Bacillus anthracis (Anthrax— Capripoxvirus (Sheep pox virus

virulent strains) and Goat pox virus)
Botulinum toxin (reportable Classical swine fever virus

quantity 0.5mg)
Ebolavirus Clostridium botulinum (Botulism;

toxin-producing strains)
Foot-and-mouth disease virus Francisella tularensis (Tularaemia)
Highly pathogenic influenza virus, Lumpy skin disease virus

infecting humans
Marburgvirus Peste-des-petits-ruminants virus
Ricin (reportable quantity 5 mg) Salmonella Typhi (Typhoid)
Rinderpest virus Vibrio cholerae (Cholera)
(serotypes O1 and O139 only)
SARS coronavirus Yellow fever virus (non-vaccine

strains)
Variola virus (Smallpox)
Yersinia pestis (Plague)
10.3 Research Approval and Reporting

Handling of any Tier 1 or Tier 2 SSBA must be approved by the IBC and no work with the SSBA can
commence until the University and facility have been registered with DoH.
The National Health Security Act 2007 requires Universities and facilities handling SSBAs to report
their holdings to DoH for inclusion on a National Register and comply with relevant security
standards. The following events must be reported to the DoH within 2 business days:
• The University starts to handle an SSBA
23

• The University starts to handle an SSBA that has not previously been included on the
National Register
• If a University that is not registered to handle an SSBA at a facility and, as a result of
its normal testing procedures, an SSBA is at least presumptively identified
In case of loss, misuse or theft the IBC must be advised immediately.
11. Laboratory Animals

11.1 Introduction
The use of animals or animal tissues for educational or research purposes is regulated in Australia by
State Government legislation; the NSW Animal Research Act 1985 and Animal Research Regulations
2010 and the Australian code for the care and use of animals for scientific purposes (8th Edition,
2013:NHMRC), which is incorporated by reference into the Animal Research Regulations.
Individuals intending to use animals as part of their teaching or research must be aware of the
associated human health risks:
• Allergens (hair, fur, urinary proteins, faeces and parasites)

• Bites, scratches and kicks
• Zoonoses (diseases transmissible from animals to humans)
• Manual handling (lifting and carrying cages, animals and feed)
• Hazardous substances (anaesthetic gases, cytotoxic drugs, radioactive materials)
• Other risks associated with animal houses such as slips (especially in wet animal
houses) and contact injuries from needles and sharps
Health surveillance may apply where as a worker you attend a pre-employment medical to ensure
the workplace can be reasonably adjusted to accommodate any medical restrictions. This is handled
in a confidential and implemented in accordance with the University Health Surveillance Program.
For more information refer to the Macquarie University Health and Safety webpage.
11.2 Use of Animals at Macquarie University

It is the responsibility of the Animal Ethics Committee (AEC)to ensure, on behalf of the University,
that animal research is conducted in accordance with the Australian code for the care and use of
animals for scientific purposes (8th Edition, 2013:NHMRC).
At Macquarie University all teaching and research proposals involving the use of live vertebrate
animals or cephalopods must have approval from the AEC before they can proceed. This includes the
use of animals in research, teaching, field trials, product testing, diagnosis, the production of
biological products, environmental studies and observational studies of wildlife. Please refer to the
Macquarie University Animal Ethics website for application forms, training resources and legislative
requirements.
If the project involves the use biohazardous materials, microorganisms classified as risk group 2 and
above, GMOs, radioactive isotopes or other hazardous substances approvals will also need to be
sought from the relevant committee and/or Officer. If working in one of the University’s Animal
24

Facilities individuals must also meet with the facility manager to ensure there is adequate space and
resources available to complete the study and to schedule training.
12. Facility Work Practices

12.1 General Rules and Regulations
Laboratories are potentially hazardous work places. Strict adherence to laboratory safety rules and
regulations can greatly reduce the risks associated with potential laboratory hazards. It is a condition
of entry that all persons must understand the general laboratory safety rules and accepts their
responsibility under WHS Legislation to adhere to the safety rules at all times.
All laboratory work shall be carried out with regard to the safety of laboratory occupants. The
following requirements apply to all laboratory personnel:
• Individuals shall familiarise themselves with the recommendations and

requirements in the laboratory safety manual.
• Individuals shall be familiar with, and shall use, the appropriate safety equipment
provided.
• Individuals, who alone know the nature and contents of their experimental materials
and apparatus, shall ensure that the apparatus (or the remains, if broken) is
decontaminated before maintenance or disposal, and that materials are processed
in accordance with laboratory policy before disposal.
Please see the Macquarie University General Laboratory Safety Guidelines and AS/NZS 2243.3
Section 2 for further information. It is recommended that individual Departments develop and
implement local laboratory safety guidelines that are designed to meet their specific needs whilst
still remaining compatible with these rules.
12.2 PC1 Facility

PC1 work practices are additional to general laboratory work practices. The following practices as
described in AS/NZS 2243.3:2010 Section 5 are to be observed when working in a PC1 facility:
• Access to the laboratory is limited

• No food or drink is to be consumed or stored in the laboratory. Eating, drinking,
smoking, shaving and the application of cosmetics shall be prohibited
• PPE worn and used in the laboratory shall comply with the requirements in AS/NZS
2243.1.
• Long hair shall be tied back
• All cultures must be clearly labelled and dated
• Do not store cultures for long periods of time on the bench. Transfer cultures to a
dedicated storage area, such as refrigerators and cold rooms
• Used sharps, syringes and needles must be placed in the approved yellow sharps
bins provided. Before placing into the yellow bins, needles must not be removed,
bent, sheared or recapped. The use of sharps shall be restricted in the laboratory for
use only when there is no alternative. Take care to prevent the dissemination of
25

material while flaming a wire loop, by drawing the loop from the cooler to the hotter
part of the Bunsen burner flame, or by using a hooded or an electric Bunsen burner
• Petri dish cultures of fungi must be sealed to prevent dispersal of spores
• Handle diagnostic kits and control sera with care as the exclusion of all pathogens
cannot be guaranteed
• Take care to minimise the production of aerosols whilst working on an open bench
• Take precautions to ensure that reading and writing materials do not become
contaminated
• Use self-adhesive labels
• Clean up all spills immediately and decontaminate the area
• Report significant spills and incidents immediately to the facility Manager
• Decontaminate benches at least daily and after each task is completed
• Remove laboratory coats and gowns and store in the facility
• Thoroughly wash hands and under fingernails before leaving the facility
12.3 PC2 Facility

The following work practices described in AS/NZS2243.3:2010 Section 5 must be followed in addition
to the general laboratory and PC1 facility work practices:
• Instruction and training in handling infectious microorganisms shall be provided to

laboratory personnel
• All individuals must receive an induction before they can work in the facility
• Potentially contaminated surfaces must be disinfected before maintenance of
equipment is conducted
• Facility shall be inspected at least annually by the IBC to ensure its containment
requirement still comply with AS/NZS 2243.3:2010 clause 5.4.4
• All clinical specimens shall be regarded as potentially hazardous. Leaking containers
must be handled in a biological safety cabinet and the outside of the container
disinfected. Where a replacement sample is obtainable, the leaking specimen shall
be sterilised and disposed of
• For work that creates aerosols, such as shaking, mixing, ultrasonic disruption, a
biological safety cabinet (BSC) or other equipment designed to contain he aerosol
must be used
• A period of at least 5 minutes shall be allowed for aerosols to settle before opening
homogeniser or sonicator containers in a BSC
• Special care must be taken when handling human blood, serum, other body fluids
and substances that are visibly contaminated with blood, as they may contain
viruses. The risk extends to human sera and derivatives used as control reagents
• Any container of viable micro-organisms transported outside the facility must be
within a second unbreakable, closed and labelled container (secondary
containment) which can be readily decontaminated. There should also be sufficient
absorbent material (such as tissue paper) placed around the primary container to
absorb any potential spill
• Potentially contaminated, reusable glassware must be pressure steam sterilised or
chemically disinfected prior to washing and re-use
26

• Minor cuts, abrasions and dermatitis should be adequately covered and kept dry
• Bacterial cultures must not be sniffed for odours
• Laboratory work books must be kept separate from all research and experimental
processes
• Protective clothing shall not be worn outside the facility and shall be
decontaminated or disinfected prior to laundering or disposal
12.4 PC3 Facilities

The following practices as described in AS/NZS 2243.3:2010 Section 5 must be followed in addition
to the general laboratory, PC1 and PC2 facility work practices:
• Facility shall be inspected at least annually by the IBC to ensure its containment
requirement still comply with AS/NZS 2243.3:2010 clause 5.4.4
• The laboratory management shall establish policies and written procedures whereby
only persons who have been advised of the biohazard, and who meet any medical
requirements, shall enter the laboratory
• An effective emergency evacuation plan is in place
• All laboratory staff have specific training in handling pathogenic organisms and in
the use of safety equipment and controls
• All laboratory procedures with risk group 3 infectious materials, shall be conducted
in a BSC of Class I, Class II or Class III
• Outer clothing and personal effects shall not be taken into the containment facility
• No one shall enter the laboratory for cleaning, servicing of equipment, repairs or
other activities before the relevant, potentially contaminated surfaces have been
decontaminated and authorisation has been obtained from the facility manager
• Dedicated cleaning equipment shall be stored within the facility
• Viable biological materials to be removed from the containment laboratory shall be
transferred to a non-breakable, sealed primary container, the external surface of
which is decontaminated before enclosure in a non-breakable sealed secondary
container
• Laboratory wastes shall be rendered safe, preferably by decontamination in a
pressure steam steriliser before professional disposal
• If a double ended pressure seam steriliser is installed across the barrier, it shall be
decontaminated after each exposure to the laboratory environment
• Protective clothing shall be removed in a predetermined appropriate order (note: in
most circumstances this involves removing the gloves then decontaminating the
hands followed by removal of eye protection, gown and respiratory protection,
taking care not to touch potentially contaminated parts of PPE when doing so, then
decontaminating hands again.
• Measures shall be taken to ensure no microbiological contamination is removed
from the facility on footwear
• In the event of a power failure, entry to the facility shall be restricted until services
have been restored.
27

12.5 GMO Physical Containment Facilities
Any person working with GMOs in a laboratory is required to follow the guidelines for containment
facilities as set out by the OGTR in addition to all other requirements relating to the Physical
Containment level as listed in the AS/NZS2243.3:2010 Section 5.
12.6 Biosecurity Approved Arrangements (AA)

Any person wishing to import microorganisms, animals, human products, plants or soil for their
research is required to have an Import Permit from the Department of Agriculture and Water
Resources (DAWR). The DAWR will assess if the products can be released on arrival or if they need to
be used in an AA facility. If they need to be used and stored in an AA facility, conditions set by the
DAWR must be met in addition to all other requirements listed in AS/NZS 2243.3:2010 (see section 9
of this manual).
13. Biological Spills

13.1 Introduction
To control the hazards associated with biological spills, every laboratory working with biohazards
must develop written emergency spill/clean-up procedures appropriate to the hazards of that
material. All laboratories working with biohazards must keep emergency spill/clean-up kits within
the laboratory area that are tailored to suit the type of biological material and risk group of the
microorganism being used in the work area. AS/NZS 2243.3:2010 provides information on the
contents of basic spill kits.
The nature of the spill will determine the type of clean-up response required factors include:
• The size of the spill (small or large)

• The risk group classification of the organisms that has been spilled and how
infectious it is
• If the spill is confined (in a BSC, incubator, refrigerator) or in the open (bench, floor)
• Whether aerosols are being produced
• If other hazards are involved (chemicals, isotopes, sharps)
Spill clean-up procedures are well documented in AS/NZS 2243.3:2010. Detailed instructions are also
available from the Macquarie University Clean up – Biological Spills Safe Working Procedure and in
Appendix 2.
13.2 Disinfectants
Characteristics of microorganisms affect their susceptibility to disinfection. All laboratory work areas
and benches should be wiped down with 70%w/v (80%v/v) ethanol at the end of each experiment.
Refer to Appendix 3 for recommended chemical disinfection in microbiological laboratories.
The DAWR also provides a list of broad spectrum disinfectants and sanitisers suitable for use in
Approved Arrangements.
28

14. Laundering of Laboratory Gowns
Laboratory gowns should be laundered on a regular basis. Before being sent to laundry facilities,
gowns used in PC2 or higher facilities must be autoclaved, unless otherwise specified. Refer to your
respective Department for laundry procedures relating to specific laboratories.
15. Disposal of Biological Waste

15.1 Introduction
Biological waste management procedures must be adopted by Macquarie University to protect the
health and safety of persons in control of or exposed to biohazardous waste in the workplace and
the community in general. Faculties and Departments must develop, implement, maintain and
monitor a biological waste management strategy. The waste management strategy adopted by
Faculties and Departments must be environmentally responsible and comply with Federal and State
legislation and any other regulatory requirements.
Laboratory waste disposal procedures should clearly outline:
• Who is responsible and the training requirements

• The categories into which waste is to be sorted or segregated
• The temporary storage facilities for waste storage
• The collection schedules
• The final disposal arrangements with a NSW Environment Protection Authority (EPA)
approved waste disposal contractor
• Records of disposal of waste in accordance with health and government
requirements
15.2 Waste Tracking Requirements

The transport of some wastes presents a high risk to the environment and human animal health.
These wastes must be tracked when transported into, within or out of NSW. The waste consignor,
transporter and receiving facility all have obligations to ensure that the waste is properly tracked.
The Protection of the Environment Operations Act 1997 (POEO Act) is the key piece of environment
protection legislation administered by the EPA.
Under the POEO Act and the NSW EPAs Environmental Guidelines: Assessment, Classification and
Management of Liquid and Non-liquid Wastes, wastes classified as Clinical and related waste are
subject to special monitoring and reporting requirements. The specific requirements of other
biosafety standards and legislation (AS/NZS 2243.3: 2010, OGTR and DAWR) should also be
consulted for additional waste handling requirements when required.
Macquarie University maintain waste disposal agreements with EPA-Licenced contractors for the
transportation and disposal of waste. All records in regard to waste transportation, facility receipt
and disposal are to be retained for 5 years. It is mandatory that all hazardous waste collection and
disposal contracts are passed through Macquarie University Research Policy and Contracts to ensure
they meet our obligations under the POEO Act.
29

15.3 Segregation of Laboratory Waste
Laboratories generate many different types of wastes. Each category of waste (chemical, biological,
clinical, sharps and radioactive) requires segregation prior to storage and disposal. All personnel
handling bagged laboratory wastes must:
• Not compress bags

• Not place hands inside the bag
• Not hold bags close to their body
Under AS/NZS 2243.1:2005 laboratory wastes should at least be sorted into the following categories:
• Non-contaminated paper and plastics which may be disposed of as general waste
(AS/NZS 2243.3:2010)
• Non-contaminated broken glass which is placed in a designated container
• Contaminated broken glass which is disposed of in a dedicated container
• Sharps (AS/NZS 2243.3:2010)
• Clinical (AS/NZS 2243.3:2010)
• Biological (AS/NZS 2243.3:2010)
• Cytotoxic
• Animal carcasses (AS/NZS 2243.3:2010, AS/NZS 2243.4:1998)
• Radioactive (AS/NZS 2243.4:1998)
• Drugs of addiction
15.4 Clinical and Biological Waste

Clinical and biological waste has the potential to cause injury, infection or public offence. All
laboratory waste contaminated with or potentially contaminated with microorganisms must be
decontaminated before final disposal. It is understood that in house decontamination may not be
possible for all biological waste generated at Macquarie University. In these circumstances
alternative arrangements will be made after consultation with the IBC and Research Policy and
Contracts to ensure the University meets obligations under current legislative requirements. It is
recommended that local waste management plans for Faculties and departments are designed and
implemented to meet their specific needs but they must be developed in accordance with:
• AS/NZS 2243.3:2010, Section 12 Contaminated materials and waste

• Protection of the Environment Operations Act 1997
• the NSW EPAs Environmental Guidelines: Assessment, Classification and
Management of Liquid and Non-liquid Wastes
• OGTR and DAWR guidelines when applicable
Clinical and biological wastes include:
• Clinical specimens or samples of human origin (e.g. blood, body fluids, tissues, other
clinical samples, swabs, bandages, wound dressing etc)
• Microbiological waste (petri-dish, other micro-organisms cultures, cell culture
materials
• Recombinant DNA waste, genetically modified organisms and materials
30

• Animal waste (animal tissue and remains, carcasses, bedding and other animal
materials)
• Quarantine waste
• Sharps waste
• Cytotoxic and pharmaceutical waste
• Radioactive waste
15.4.1 Microorganisms, clinical or other infectious waste

As defined in AS/NZS 2243.3:2010, wastes contaminated with microorganisms, clinical or other
infectious waste can be treated by either two methods depending on local requirements:
Best Practice
Option 1: Wastes able to be rendered non-hazardous are to be done so by autoclaving (pressure

steam sterilisation). Wastes are to be sealed in opaque impervious bags that render the waste
“unrecognisable”. If waste is to be transported outside of the laboratory to autoclave facilities, it is
to be done in a secondary sealed, leak-proof, unbreakable container. Although considered non-
hazardous after autoclaving, the waste is deposited into the dedicated and locked contaminated
waste bins and awaits collection by an EPA approved contractor. Liquid cultures that have been
thoroughly decontaminated by pressure steam sterilisation may be disposed of to sewer (sink).
Disposal by this method requires monitoring of the autoclave sterilisation cycles to ensure that the
waste is thoroughly decontaminated prior to disposal. Monitoring includes the use of steam
indicators (autocloave tape and indicator strips) or chemical or biological indicators.
Option 2: Wastes that cannot be rendered non-hazardous prior to disposal must be sealed in
appropriately labelled “yellow contaminated waste bags” at point of generation. These bags must be
transported from the laboratory area in a secondary sealed, leak-proof, unbreakable container
(garbage bin with sealable lid). Waste bags are to be placed in dedicated and locked contaminated
waste bins until collection by an EPA approved contractor for disposal by incineration or autoclaved
and shredded.
Disposal by this method is subject to university approval to ensure waste obligations are met and
that staff have been trained in the safe handling of hazardous wastes.
15.4.2 GMO waste

OGTR mandates that recombinant DNA or GMOs be rendered non-hazardous before final disposal.
For detailed instructions please consult the OGTR Guidelines for the Transport, Storage and Disposal
of GMOs. GMO waste can be treated by either two methods depending on local requirements:
Best Practice
Option 1: Wastes able to be rendered non-hazardous are to be done so by autoclaving (pressure

steam sterilisation). Wastes are to be double bagged and sealed in suitable impervious bags that
render the waste “unrecognisable”. If waste is to be transported outside of the laboratory to
autoclave facilities, it is to be done in a secondary sealed, leak-proof, unbreakable container.
Although considered non-hazardous after autoclaving, the waste is deposited into the dedicated and
locked contaminated waste bins and awaits collection by an EPA approved contractor. Liquid GMO
31

cultures that have been thoroughly decontaminated by pressure steam sterilisation may be disposed
of to sewer (sink).
waste is thoroughly decontaminated prior to disposal. Monitoring includes the use of steam
indicators (autocloave tape and indicator strips) or chemical or biological indicators.
Option 2: Wastes are to be placed into lockable GMO dedicated bins within the laboratory. Once full,
bin lids are to be permanently locked. Prior to bins being loaded onto the transporter trolley and
removed from the laboratory, external surfaces must be decontaminated. Using the transporter
trolley, full bins are to be store in a dedicated and locked storage area for the EPA approved
contractor for disposal.
Disposal by this method is subject to university approval to ensure waste obligations are met
under OGTR and EPA legislation.
15.4.3 Sharps waste

Sharps must be placed into a sharps container as soon as possible after use. To avoid needlestick
injuries, needles must not be re-capped or bent and disposable needles/syringe sets should be
discarded as a single unit. Sharps must be disposed of in approved yellow sharps containers which
comply with AS4031-1992 Non-reusable containers for the collection of sharp medical items used in
health care areas. Sharps containers are not be filled past the indicated line and once full, the
sharps container must be sealed and placed in a yellow contaminated waste bags before being
disposed of in lockable contaminated waste bins. Used sharps containers must not be emptied or
reused under any circumstances.
15.4.4 Cytotoxic waste

Cytotoxic waste must be segregated from all other waste streams wherever possible and must be
placed into dedicated purple cytotoxic waste bags, lockable bin or the purple cytotoxic sharps
containers. If bins are to be used, once full they need to be locked permanently with the side locks,
decontaminated on all external surfaces and stored in a dedicated lockable area for disposal
contractor. Cytotoxic waste bags and sharps containers must be placed into a purple cytotoxic
clinical waste bin for contractor. Disposal is by incineration at 1100˚C.
15.4.5 Animal carcasses
15.4.5.1Non-Biohazardous animal carcasses

Non-biohazardous animal carcasses are those that; are used for dissection purposes only in teaching;
are surplus to experimental requirements; do not contain any GMOs, SMOs or SSBAs; or those that
are not mandated under quarantine regulations. The EPA classifies non-biohazardous animal
carcasses as putrescible (organic) waste which means they can be disposed of, without treatment,
directly for deep burial at a landfill facility. Animals suitable for this disposal are required to be
packaged into black garbage bags and de-identified of any labelling. Carcasses are to be refrigerated
at 4˚C or frozen until collected.
15.4.5.2 GMO animal carcasses

GMO animals that do not contain any hazardous or GMO microorganisms are rendered non-
biohazardous through euthanasia. Such carcasses can then be disposed of as non-biohazardous.
32

Animals suitable for this disposal are required to be packaged into black garbage bags and de-
identified of any labelling. Carcasses are to be refrigerated at 4˚C or frozen until collected.
15.4.5.3 Biohazardous and quarantine regulated animal carcasses

Imported animals or animal carcasses contaminated, or potentially contaminated with biohazardous
materials, GMOs, SMOs or imported biologicals must be rendered non-hazardous prior to disposal. If
facilities exist, animal carcasses may be rendered safe by autoclaving on site prior to landfill disposal.
waste is thoroughly decontaminated prior to disposal.
If in-house autoclaving is not available, animal carcasses are to be double bagged and held in the
freezer before being transported by an approved transporter to the designated waste disposal
contractor for high temperature incineration or other methods approved by the Department of
Agriculture and Water Resources. For materials and animals regulated by quarantine the methods of
disposal must be consistent with the import permit.
Disposal by this method is subject to university approval to ensure waste obligations are met
under OGTR and EPA legislation
15.4.5.4 Perfused animal carcasses

Animals and animal tissues perfused with formaldehyde or paraformaldehyde are deemed non-
biohazardous. However, these animals are unable to be autoclaved due to the generation of toxic
fumes. Perfused animals and animal tissues must be placed in plastic bags with a label indicating the
chemical hazard and segregated from non-perfused materials. Carcasses are to be refrigerated at
4˚C or frozen until collected.
15.4.6 Drugs of addiction

Drugs of addiction are substances which are addiction producing or potentially addiction producing.
Possession and use are strictly limited. Destruction of a drug of addiction may be carried out only by
or under the direct personal supervision of a person authorised by the NSW Ministry of Health such
as Pharmaceutical Services Senior Pharmaceutical Officers, a police officer or another authorised
individual. The destruction is to be recorded in the facilities drug register, and show the date, the
name of the person who carried out the task and their registration number. Please refer to the local
Facility Manager for the disposal procedure of empty containers used to store drugs of addiction.
16. Appendix 1 Biosafety Legislation

Commonwealth Legislation
Biological Controls Act 1984
Biosecurity Act 2015
Crimes (Biological Weapons) Act1976
Crimes (Biological Weapons) Regulation 1980
Gene Technology Act 2000
33

Gene Technology Regulations 2001
National Health Security Act 2007
National Health Security Regulations 2008
Prohibition of Human Cloning Act 2002
Quarantine Act 1908
Research Involving Human Embryos Act 2002
NSW Legislation
Anatomy Act 1977
Animal Research Act 1985
Animal Research Regulation 2010
Biological Control Act 1985
Gene Technology (NSW) Act 2003
Human Tissue Act 1983
Human Cloning for Reproduction and Other Prohibited Practices Act 2003
NSW Work Health and Safety Act 2011
NSW Work Health and Safety Regulations 2011
Protection of the Environment Operations Act 1997
Public Health Act 1991
Public Health (Microbial Control) Regulation 2000
Research Involving Human Embryos (NSW) Act 2003
Australian Standards
AS/NZS 2243.3:2010 Microbiological Safety and Containment
AS/NZS 2243.1:2005 Safety in Laboratories – Planning and Operational Aspects
AS/NZS 2982:2010 Laboratory Design and Construction
AS/NZS 3816:1998 Management of Clinical and related wastes
AS/NZS 4501.1:2008 Occupational Protective Clothing
AS/NZS 4501.2:2006 Occupational Protective clothing
Other
SafeWork NSW
SafeWork NSW – Pregnancy at Work – Guide 2002
Australian Immunisation Procedures Handbook (10th Edition, NHMRC)
World Health Organisation Biosafety Manual
34

17. Appendix 2 Clean up biological spills – Safe Work Procedure
35

36

37

18. Appendix 3 Summary of recommended disinfectants for microbiological
laboratories
Site or equipment Routine or preferred method Acceptable alternative
or usage
Benches and surfaces (not Alcohols e.g. 70%w/v (=80%v/v) Synthetic phenolics*
obviously contaminated) ethyl or 60-70% v/v isopropyl –
swabbed
Biological safety cabinet (BSC) Alcohols e.g. 70%w/v (=80%v/v) For BSC with capture hoods,
work surfaces ethyl – swabbed or high glutaraldehyde** (with cabinet
concentration chlorine fan operating ) – swabbed (See
disinfectant at 5000 – 10 000 AS/NZS 2647)
p.p.m. (0.5 – 1%) or other
disinfectant depending on the
organism
Room space e.g. laboratory or Formaldehyde vapour Vaporized hydrogen peroxide)
animal room, BSC before or chlorine dioxide
servicing or testing or after a
major spill
Centrifuge rotor or sealable Disinfection not the preferred glutaraldehyde** for 10 min or
bucket after leakage or method. Pressure steam synthetic phenolics* for
breakage sterilising at 121°C for 15 min bacterial spills for 10 min
recommended
Centrifuge bowl after leakage or glutaraldehyde** for 10 min Synthetic phenolics* for
breakage (swabbed twice within the 10 bacterial spills for 10 min
min nperiod then wiped with
water)
Discard containers (pipette jars) Chlorine disinfectant at 2000 – Synthetic phenolics* for
2500 p.p.m. (0.2% - ).25%) bacteriological work (Changed
weekly) or detergent with
pressure steam sterilising for
virus work
Equipment surfaces before Surfaces disinfected according Alcohol (80%v/v ethyl or 60-
services or testing to manufacturer’s instructions 70% v/v isopropyl) except when
its flammability poses a hazard
or glutaraldehyde** then water
Gnotobiotic animal isolators Peracetic acid at 2% v/v –
swabbed
Hands disinfection Chlorhexidine (0.5 – 4 % w/v) in Isopropyl (60 – 70% v/v or ethyl
alcoholic formulations for 2 min alcohol (80% v/v) with
* emollients or Povidone-iodine
(0.75 – 1% av I) for 2 min
Hygienic hand wash Chlorhexidine (4%w/v) in Detergent cleansers or soap for
detergent formulation (or 15 s
alcoholic formulations) for 15 S
* Dilute according to manufacturer’s instructions
** Glutaraldehyde as 2% w/v activated aqueous or 1% w/v glycol-complex formulations
38

Site or equipment Routine or preferred method Acceptable alternative
or usage
Spills of blood/serum (or viral High concentration chlorine at glutaraldehyde** for 10 min
cultures) 5000 – 10 000 p.p.m (0.5 – 1%)
for 10 min (active against
hepatitis viruses and HIV)
Spills of bacterial cultures High concentration chlorine at Synthetic phenolics* unaffected
5000 – 10 000 p.p.m (0.5 – 1%) by organic load) for 10 min
or Iodophor * for 10 min
Animal cages Wash with detergent followed
by pressure steam sterilising at
121°C for 15 min if infected
Drains and animal rooms Sodium Hydroxide 1M
(surfaces)
* Dilute according to manufacturer’s instructions
** Glutaraldehyde as 2% w/v activated aqueous or 1% w/v glycol-complex formulations
Note: QAP facilities must follow disinfectants approved by the Department of Agriculture and
Water Resources. Please visit their website below:
http://www.agriculture.gov.au/import/general-info/qap/broad-spectrum-disinfectants
39

19. Appendix 4: Good Hand washing technique
Source: World Health Organisation
40

20. Appendix 5: The hierarchy of risk control
Source: SafeWork NSW, Code of Practice: How to manage work health and safety risks
http://www.workcover.nsw.gov.au/__data/assets/pdf_file/0009/15201/how-manage-work-health-
safety-risks-code-of-practice-3565.pdf
20.1 Key Terms

Hazard means a situation or thing that has the potential to harm a person. Hazards at work may
include manual tasks, biological, radiation, hazardous chemicals, noise, electricity, machinery and
equipment.
Risk is the possibility that harm (death, injury or illness) might occur when exposed to a hazard.
Risk control means taking action to eliminate health and safety risks so far as is reasonably
practicable, and if that is not possible, minimising the risks so far as is reasonably practicable.
Eliminating a hazard will also eliminate any risks associated with that particular hazard.
20.2 Hierarchy of risk control

The ways of controlling risks are ranked from highest level of protection and reliability to the lowest
as shown in the below figure. This ranking is known as the hierarchy of risk control. Biohazard risk
assessments include this hierarchy to assist in managing the risks associated with working with
biological agents. Elimination of a hazard is the most effective control. If this is not reasonably
practicable, you must minimise the risk by working through the other alternatives in the hierarchy.
41

Level 1 control measures are the most effective and involve eliminating the hazard and associated
risk. For example, you can eliminate the risk of working with a risk group 2 organism by eliminating
its infectivity e.g. irradiation.
Level 2 control measures are used when it is not reasonably practicable to eliminate the hazard and
associated risk. There are three approaches to reduce risk at this level:
Substitute the hazard with something safer. For example, using a non-human pathogenic strain
Engineering controls / Isolate the hazard by physically separating the source of harm from people by
distance or using barriers. For example, working inside a physical containment facility or conducting
work inside a biosafety cabinet.
Level 3 control measures These controls are the least effective in minimising risks and should be
used as a last resort or to supplement the higher-level control measures. Two approaches to reduce
risk in this way are:
Administrative controls are work methods or procedures that are designed to minimise exposure to
a hazard. For example, providing training for working with biohazardous materials, laboratory
inductions, safe work procedures and signage.
Personal protective equipment (PPE) is the final control measure and limits exposure to the hazard
only if it is used correctly. For example, laboratory coats, eye protection, face masks and gloves.
42

21. Appendix 6: Step by step process for the safe removal of PPE
(Source: Centre for Disease Control)
43

22. Appendix 7: Examples of microorganisms for risk groups 2 and 3
22.1 Risk group 2 microorganisms
Examples of risk group 2 bacteria
Abiotrophia spp. Gordona spp.
Acidovorax spp. Haemophilus influenzae, H. ducreyi
Acinetobacter spp. Helicobacter pylori
Actinobacillus spp. Kingella kingae
Actinomyces pyogenes Klebsiella spp.
Aeromonas hydrophila Legionella spp.
Afipia spp. Listeria spp.
Arcanobacterium haemolyticum Moraxella spp.
Bacillus cereus Mycobacterium spp.
Bartonella henselae, B. quintana, B. vinsonii, B. Mycoplasma pneumoniae, M. fermentans
elizabethiae, B. weisii
Bordetella pertussis Neisseria gonorrhoeae, N. meningitidis
Brucella ovis Nocardia spp.
Burkholderia spp. (except B. mallei and B. pseudomallei) Oligella spp.
Campylobacter coli, C. fetus, C. jejuni Pasteurella spp.
Capnocytophaga canimorsus Rhodococcus equi
Chlamydia spp. (except avian strains of C. psittaci) Salmonella serovars
Clostridium spp. (except those known to be Shigella spp.
nonpathogenic)
Corynebacterium diphtheriae, C. renale, C. Sphaerophorus necrophorus
pseudotuberculosis
Dermatophilus congolensis Staphylococcus aureus
Edwardsiella tarda Stenotrophomonas maltophilia
Eikenella corrodens Streptobacillus moniliformis
Enterococcus spp. (Vancomycin-resistant strains) Streptococcus pyogenes, S. pneumoniae
Erysipelothrix rhusiopathiae Ureaplasma ureolyticum
Pathogenic Escherichia coli (except Verocytotoxin- Vibrio cholerae, V. parahaemolyticus, V. vulnificus
producing (VTEC) strains and genetically crippled strains)
Fusobacterium spp. Yersinia spp. (except Y. pestis)
Gardnerella vaginalis
44

Risk group 2 bacteria requiring special precautions
Borrelia (mammalian) spp. Mycobacterium spp. other than M. tuberculosis

complex
Burkholderia pseudomallei Mycobacterium tuberculosis complex (except multi-
drug resistant strains)
Clostridium botulinum Neisseria meningitidis (except for Serogroup B)
Clostridium tetani Neisseria meningitidis (Serogroup B)
Corynebacterium diphtheriae Salmonella Typhi
Coxiella burnetii (smears and serology from samples) Shigella dysenteriae Type 1
Escherichia coli Vero cytotoxin-producing strains, e.g. Treponema pallidum
0157, 0111
Leptospira interrogans (all serovars) Treponema pertenue
Listeria monocytogenes
Examples of risk group 2 parasites (infective stages only)

Ancylostoma duodenale Naegleria fowleri
Ascaris lumbricoides Necator americanus
Babesia divergens Opisthorchis spp. (including Clonorchis sinensis)
Babesia micro-organismsti Plasmodium (human and simian)
Brugia spp. Strongyloides stercoralis
Cryptosporidium spp. Taenia saginata
Echinococcus spp. Taenia solium
Entamoeba histolytica Toxocara canis
Giardia duodenalis (also known as Giardia lamblia and Toxoplasma gondii
Giardia intestinalis)
Hymenolepis diminuta Trichinella spiralis
Hymenolepis nana (human origin) Trypanosoma brucei subspp.
Leishmania (mammalian) spp. Trypanosoma cruzi
Loa loa Wuchereria bancrofti
Examples of risk group 2 fungi

Aspergillus fumigatus and A. flavus Epidermophyton floccosum
Candida albicans Micro-organismssporum spp.
Cryptococcus neoformans Sporothrix schenckii
45

Examples of risk group 2 viruses and prions
Adenoviridae Respiratory syncytial virus
Adenovirus Respirovirus
Arenaviridae Parainfluenza 1, 2, 3 and 4
Arenavirus Parvoviridae
Lymphocytic choriomeningitis (LCM) non-neurotropic Human parvovirus
strains
Tacaribe virus complex Picornaviridae
Caliciviridae Encephalomyocarditis
Feline calicivirus Encephalomyocarditis virus
Norwalk-like Enterovirus
Sapporo-like Coxsackie
Largovirus Echo
Rabbit haemorrhagic disease Entero
Coronaviridae Parecho
Coronavirus Polio 1, 2 and 3
Flaviviridae Rhinovirus
Flavivirus Hepatovirus
Dengue 1, 2, 3 and 4 Hepatitis A
Japanese encephalitis (Nakayama strain) Poxviridae
Kokobera Orthopoxvirus
Kunjin Vaccinia
Murray Valley encephalitis Parapoxvirus
Sarafend Orf
Saumarez Reef Prions
Yellow fever (strain 17D) Gerstmann-Sträussler syndrome,
Hepacivirus Kuru and Creutzfeldt-Jakob agents (See Note 1 and
Clause 3.5)
Hepatitis C Reoviridae
Hepadnaviridae Orbivirus
Duck hepatitis B Bluetongue viruses (endemic strains)
Hepatitis B Epizootic haemorrhagic disease viruses of deer
(endemic strains)
Herpesviridae Rotavirus
Alphaherpesvirinae Rotavirus
Simplex Retroviridae (serology, other tests on samples)
Varicella Oncovirinae
Betaherpesvirinae Human lymphotropic virus 1
Cytomegalovirus Human lymphotropic virus 2
Gammaherpesvirinae Lentivirinae
Herpes 6 and 7 Human immunodeficiency virus
Lymphocryptovirus (EB-like viruses) Togaviridae
Orthomyxoviridae Alphavirus
Influenza (except those in Table 3.10) Barmah Forest
Paramyxoviridae Ross River
Paramyxovirinae Semliki Forest
46

Morbillivirus Arterivirus
Measles Equine viral arteritis
Rubulavirus Rubivirus
Menangle Rubella
Mumps Hepatitis D
Newcastle disease virus (non-virulent endemic strains) Hepatitis E
Pneumovirus
22.2 Risk group 3 microorganisms

Examples of risk group 3 bacteria
Bacillus anthracis Coxiella burnetii (cultures, animal work and
concentrates)
Bartonella bacilliformis Francisella tularensis (type A)
Burkholderia mallei Multi-drug resistant Mycobacterium tuberculosis
complex
Brucella spp. (except B. ovis) Rickettsia spp.
Chlamydia psittaci (avian strains) Yersinia pestis
Examples of risk group 3 fungi

Aphanomyces astaci Histoplasma spp.
Blastomyces dermatitidis Paracoccidioides brasiliensis
Ceratocystis ulmi Phytophthora cinnamomi
Coccidioides immitis
Examples of risk group 3 viruses

Arenaviridae Mapuera
Arenavirus Newcastle disease (exotic strains)
Lymphochoriomeningitis (LCM) neurotropic strains Retroviridae (from cultures and concentrates)
Bunyaviridae Oncovirinae
Group C Human lymphotropic virus 1
Oropouche Human lymphotropic virus 2
Phlebovirus Lentivirinae
Hantavirus Human immunodeficiency virus
Hantaan and related viruses Rhabdoviridae
Flaviviridae Lyssavirus
Flavivirus Australian bat lyssavirus
Japanese encephalitis Rabies fixed strain (CVS II)
St Louis encephalitis Togaviridae
Tick-borne viruses Alphavirus
West Nile Eastern equine encephalitis
Yellow fever Western equine encephalitis
Paramyxoviridae Venezuelan equine encephalitis
Rubulavirus
47

23. Appendix 8 Examples of zoonotic diseases
Host Disease in humans Mode of transmission

Sheep Brucellosis Direct contact with infected
semen, foetuses, foetal
membranes and vaginal
secretions
Sheep Q-fever Inhalation, direct contact with

amniotic fluid or placenta
Sheep, non-human primates Campylobacteriosis Ingestion
Sheep, non-human primates Tuberculosis Inhalation, direct contact,

ingestion
Macaques Cercopithecine (B virus) Direct contact, bite wounds

encephalitis
Rodents, Farm and wild animals Leptospirosis Weil’s disease Direct contact, urine,
contaminated soil and water
Rodents Rabbits Sheep Farm Ringworm/Tapeworm Direct contact, soil may be a

animals reservoir
Farm animals Rodents Salmonellosis Ingestion, Inhalation Direct

Amphibians contact
Farm animals Rodents Giardia/Parasitic infections Ingestion Direct contact

Amphibians
Zebrafish Amphibians Aquarium Bacterial/Protozoal infections Direct contact Ingestion

water
Bats Australian Bat Lyssavirus Bites/scratches
24. Appendix 9 Document History
Approved by: Macquarie University Institutional Biosafety Committee
Date of implementation: November 2015
Major Review date [5 years]: November 2020
Version Number Activity Date

1.3 Document Approved November 2015
1.4 Document amended to reflect October 2017
new approval system and
Biosecurity Act 2015
1.5 Websites updated June 2018
48

49


Biosafety and Biosecurity Manual V1.5

Uploaded by

Copyright:

Available Formats

Biosafety and Biosecurity Manual V1.5

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Biosafety and Biosecurity Manual V1.5

Uploaded by

Copyright:

Available Formats

Biosafety and Biosecurity Manual

Macquarie University Biosafety and Biosecurity Manual Version 1.5

Macquarie University Biosafety and Biosecurity Manual Version 1.5

Macquarie University Biosafety and Biosecurity Manual Version 1.5

Macquarie University Biosafety and Biosecurity Manual Version 1.5

Macquarie University requires that:

• Biological materials are obtained, transported, stored and disposed of in an ethical

Macquarie University Biosafety and Biosecurity Manual Version 1.5

2.2 Institutional Biosafety Committee

2.3 University Biosafety Officer

2.4 Deans and Heads of Department

2.5 Laboratory and Facility Managers

2.6 Chief Investigators

Macquarie University Biosafety and Biosecurity Manual Version 1.5

It is mandatory for Chief Investigators to undertake a thorough risk management assessment to

For a comprehensive guide to immunisations please visit:

• Wounds where disinfection has been delayed by more than 4 hours

Those at risk of tetanus include:

Macquarie University Biosafety and Biosecurity Manual Version 1.5

3.2 Precautions for Pregnant Women

3.3 Personal Hygiene

Macquarie University Biosafety and Biosecurity Manual Version 1.5

4.2 Biosafety Management and Support

• Microorganisms classified as risk group 2 and above

Macquarie University Biosafety and Biosecurity Manual Version 1.5

Macquarie University introductory biosafety course

4.3 Risk management

4.3.1 Hierarchy of control

The hierarchy of control involves the following six steps;

Macquarie University Biosafety and Biosecurity Manual Version 1.5

4.3.2 Responsibility of the Chief Investigator

4.3.3 Responsibility of Research and Technical Personnel

• Read the relevant risk assessment and relevant guidance material.

4.3.4 Register of Biological Hazards

Macquarie University Biosafety and Biosecurity Manual Version 1.5

4.3.7 Laboratory Access and Authorisation

4.3.8 Personal Protective Equipment

Macquarie University Biosafety and Biosecurity Manual Version 1.5

4.3.9 Working After Hours

4.3.10 Safety Documentation

Biosafety Management support page

Macquarie University Health and Safety

Macquarie University Biosafety and Biosecurity Manual Version 1.5

• Good microbiological practices (aseptic techniques)

When used in combination with physical containment work practices described in

6. Microorganisms and Biohazardous Materials

Laboratory acquired infections may arise through:

• Inhalation through the production of aerosols from processes such as centrifugation,

Macquarie University Biosafety and Biosecurity Manual Version 1.5

6.2 Risk groups

6.2.2 Risk group classification for plant infectious microorganisms

Macquarie University Biosafety and Biosecurity Manual Version 1.5

6.2.3 Risk group classification for invertebrates carrying infectious microorganisms

6.3 Physical Containment

Macquarie University Biosafety and Biosecurity Manual Version 1.5

7. Work with Genetically Modified Organisms (GMOs)

A GMO is defined as:

• An organism that has been modified by gene technology, or

Dealings with, in relation to a GMO, means the following:

• Conduct experiments with the GMO